| The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors D Zingg, J Debbache, SM Schaefer, E Tuncer, SC Frommel, P Cheng, ... Nature communications 6 (1), 6051, 2015 | 335 | 2015 |
| The histone methyltransferase Ezh2 controls mechanisms of adaptive resistance to tumor immunotherapy D Zingg, N Arenas-Ramirez, D Sahin, RA Rosalia, AT Antunes, J Haeusel, ... Cell reports 20 (4), 854-867, 2017 | 278 | 2017 |
| Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma O Shakhova, D Zingg, SM Schaefer, L Hari, G Civenni, J Blunschi, ... Nature cell biology 14 (8), 882-890, 2012 | 276 | 2012 |
| Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2 N Arenas-Ramirez, C Zou, S Popp, D Zingg, B Brannetti, E Wirth, ... Science translational medicine 8 (367), 367ra166-367ra166, 2016 | 128 | 2016 |
| EZH2-mediated primary cilium deconstruction drives metastatic melanoma formation D Zingg, J Debbache, R Peña-Hernández, AT Antunes, SM Schaefer, ... Cancer cell 34 (1), 69-84. e14, 2018 | 115 | 2018 |
| Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma PF Cheng, O Shakhova, DS Widmer, OM Eichhoff, D Zingg, SC Frommel, ... Genome biology 16, 1-16, 2015 | 105 | 2015 |
| Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma O Shakhova, P Cheng, PJ Mishra, D Zingg, SM Schaefer, J Debbache, ... PLoS genetics 11 (1), e1004877, 2015 | 100 | 2015 |
| Yin Yang 1 orchestrates a metabolic program required for both neural crest development and melanoma formation S Varum, A Baggiolini, L Zurkirchen, ZK Atak, C Cantù, E Marzorati, ... Cell stem cell 24 (4), 637-653. e9, 2019 | 51 | 2019 |
| Responsiveness of fibrocytes to toll-like receptor danger signals C Balmelli, MP Alves, E Steiner, D Zingg, N Peduto, N Ruggli, H Gerber, ... Immunobiology 212 (9-10), 693-699, 2008 | 50 | 2008 |
| SMAD signaling promotes melanoma metastasis independently of phenotype switching E Tuncer, RR Calçada, D Zingg, S Varum, P Cheng, SN Freiberger, ... The Journal of clinical investigation 129 (7), 2702-2716, 2019 | 48 | 2019 |
| Truncated FGFR2 is a clinically actionable oncogene in multiple cancers D Zingg, J Bhin, J Yemelyanenko, SM Kas, F Rolfs, C Lutz, JK Lee, ... Nature 608 (7923), 609-617, 2022 | 41 | 2022 |
| Sulfate-driven elemental sparing is regulated at the transcriptional and posttranscriptional levels in a filamentous cyanobacterium A Gutu, RM Alvey, S Bashour, D Zingg, DM Kehoe Journal of bacteriology 193 (6), 1449-1460, 2011 | 21 | 2011 |
| Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system S Klarenbeek, CW Doornebal, SM Kas, N Bonzanni, J Bhin, ... Oncoimmunology 9 (1), 1724049, 2020 | 13 | 2020 |
| Rare, yet relevant tumor cells-A new twist to melanoma cell plasticity D Zingg, L Sommer Pigment Cell & Melanoma Research 31, 7-10, 2018 | 4 | 2018 |
| MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer J Bhin, J Yemelyanenko, X Chao, S Klarenbeek, M Opdam, Y Malka, ... Journal of Experimental Medicine 220 (11), e20211743, 2023 | 1 | 2023 |
| The epigenetic repressor EZH2 controls tumour escape mechanisms during immunotherapy D Zingg, N Arenas-Ramirez, RA Rosalia, AT Antunes, J Haeusel, ... European Journal of Cancer 1 (61), S64, 2016 | | 2016 |
| Role of integrated TGF-β superfamily signaling in melanoma progression E Tuncer, D Zingg, P Cheng, A Antunes, J Haeusel, CX Deng, I Kleiter, ... European Journal of Cancer 1 (61), S93, 2016 | | 2016 |
| Roles of the Epigenetic Modifier EZH2 in Melanoma DK Zingg University of Zurich, 2015 | | 2015 |
| The epigenetic modifier EZH2 drives metastatic melanoma progression D Zingg, S Schaefer, E Tuncer, S Frommel, J Debbache, P Cheng, ... Pigment Cell & Melanoma Research 27 (6), 2014 | | 2014 |
| Role of the pluripotency marker Sox2 in melanoma formation and maintenance S Schäfer, G Restivo, D Zingg, P Cheng, O Shakhova, S Nicolis, ... Pigment Cell & Melanoma Research 27 (6), 1226-1227, 2014 | | 2014 |
Lukas SommerUniversity of ZurichVerified email at anatomy.uzh.ch
